TARA Biosystems Harnessing Human Biology + Data to Transform Cardiac Drug Discovery
Tara Biosystems provides predictive, in vitro human cardiac tissue models for use in drug discovery, safety assessment and translational medicine. Tara Biosystems offers a high-fidelity solution that is based on human stem cell-derived cardiac tissue matured to physiologically relevant adult-like levels and provides direct measures of cardiac functionality, including contractile force. The company is dedicated to pioneering predictive cardiac tissue models that enable the faster, safer, and more reliable development of new medicines.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 23, 2020 | Series A | $10M | 1 | — | — | Detail |
Oct 16, 2017 | Series A | $9M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Trancos Ventures | — | Series A |